AURINIA Trademark

Trademark Overview

On Tuesday, September 12, 2017, a trademark application was filed for AURINIA with the United States Patent and Trademark Office. The USPTO has given the AURINIA trademark a serial number of 87604403. The federal status of this trademark filing is REGISTERED as of Tuesday, July 27, 2021. This trademark is owned by Aurinia Pharmaceuticals Inc.. The AURINIA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

(Based on 44(e)) Pharmaceutical preparations for the treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis

(Based on 44(e)) (Based on Use in Commerce) Research and development of medicinals and pharmaceuticals
aurinia

General Information

Serial Number87604403
Word MarkAURINIA
Filing DateTuesday, September 12, 2017
Status700 - REGISTERED
Status DateTuesday, July 27, 2021
Registration Number6430762
Registration DateTuesday, July 27, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements

Goods and Services(Based on 44(e)) Pharmaceutical preparations for the treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis
Goods and Services(Based on 44(e)) (Based on Use in Commerce) Research and development of medicinals and pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 16, 2017
Primary Code042
First Use Anywhere DateWednesday, November 30, 2016
First Use In Commerce DateWednesday, November 30, 2016

Trademark Owner History

Party NameAurinia Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressVictoria, BC V8Z 7X8
CA
Party NameAurinia Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressVictoria, BC V8Z 7X8
CA
Party NameAurinia Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressVictoria, BC V8Z 7X8
CA

Trademark Events

Event DateEvent Description
Tuesday, July 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 1, 2021ASSIGNED TO LIE
Tuesday, March 30, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 4, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 4, 2020INQUIRY TO SUSPENSION E-MAILED
Friday, December 4, 2020SUSPENSION INQUIRY WRITTEN
Thursday, November 12, 2020LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, May 6, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 6, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, May 6, 2020SUSPENSION LETTER WRITTEN
Tuesday, April 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 13, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, October 21, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, October 21, 2019INQUIRY TO SUSPENSION E-MAILED
Monday, October 21, 2019SUSPENSION INQUIRY WRITTEN
Friday, September 27, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, February 25, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 25, 2019LETTER OF SUSPENSION E-MAILED
Monday, February 25, 2019SUSPENSION LETTER WRITTEN
Friday, February 1, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 30, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, August 4, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, August 4, 2018INQUIRY TO SUSPENSION E-MAILED
Saturday, August 4, 2018SUSPENSION INQUIRY WRITTEN
Monday, July 16, 2018LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, July 13, 2018ASSIGNED TO LIE
Saturday, December 16, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, December 16, 2017LETTER OF SUSPENSION E-MAILED
Saturday, December 16, 2017SUSPENSION LETTER WRITTEN
Friday, December 15, 2017ASSIGNED TO EXAMINER
Saturday, September 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 15, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

aurinia disorders based research commerce development pharmaceuticals medicinals nephritis opthamalogical preparations